ZEB2 and ovarian cancer: Zinc finger E-box binding homeobox 2 (ZEB2) was ultimately shown to be the miR-205 gene target, completing the analysis of HOTTIP-miR-205-ZEB2 as the novel axis that is functionally engaged in determining the resistance of ovarian cancer cells to cisplatin (Dong et al. 2021).